References
- Galvani D. W., Cawley J. C. The current status of interferon α in haemic malignancy. Blood Reviews 1990; 4: 175–180
- Baron S., Tyring S. K., Fleischmann R., et al. The interferons: mechanisms of action and clinical applications. Journal of the American Medical Association 1991; 266: 1375–1383
- Einat M., Resnitzky D., Kimchi A. Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 1985; 313: 597–600
- Chang A. Y.C., Keng P. C. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Research 1987; 47: 4338–4341
- Schlom J. Monoclonal Antibodies: They're more and less than you think. Molecular Foundations of Oncology, S. Broder. Williams & Wilkins, Baltimore 1991; 95–134
- Merigan T. C., Sikora K., Breeden J. H., et al. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. New England Journal of Medicine 1978; 299: 1449–1453
- Gilewski T. A., Richards J. M. Biologic response modifiers in non-Hodgkin's lymphomas. Seminars in Oncology 1990; 17: 74–87
- Horning S. J., Merigan T. E., Krown S. E., et al. Human interferon alpha in malignant lymphoma and Hodg-kin's disease. Cancer 1985; 56: 1305–1310
- Quesada J. R., Talpaz M., Rios A., et al. Clinical toxicity of interferons in cancer patients: A review. Journal of Clinical Oncology 1986; 4: 234–243
- Wadler S., Schwartz E. L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: A review. Cancer Research 1990; 50: 3473–3486
- Kuzel T. M., Gilyon K., Springer E., et al. Interferon Alfa-2a combined with phototherapy in treatment of cutaneous T-cell lymphoma. Journal of the National Cancer Institute 1990; 82: 203–207
- Rohatiner A. Z.S., Richards M. A., Barnett M. J., et al. Chlorambucil and interferon for low grade non-Hodgkin's lymphoma. British Journal of Cancer 1987; 55: 225–226
- Ozer H., Anderson J. R., Peterson B. A., et al. Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma. Investigational New Drugs 1987; 5: S27–33
- Chisesi T., Capnist G., Vespignani M., Dini E. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Cancer Treatment Reviews 1988; 15(Suppl. A)27–33
- Clark R. H., Dimitrov N. V., Axelson J. A., et al. A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy. American Journal of Clinical Oncology 1989; 12: 75–77
- Karanes C., Ratanatharathorn V., Jones S., et al. Sequential chlorambucil and recombinant DNA alpha-2 IFN (intron-A) in the treatment of low grade lymphomas-A SWOG phase II study. Blood 1986; 68(Suppl 1)239a, (abstr.)
- Price C. G.A., Rohatiner A. Z.S., Steward W., et al. Interferon-α2b in the treatment of follicular lymphoma: preliminary results of a trial in progress. Annals of Oncology 1991; 2(Suppl. 2)141–145
- Mandelli F., Awisati G., Amadori S., et al. Maintenance treatment with recombinant interferon alpha-2b in patients with multiple myeloma responding to conventional induction chemotherapy. New England Journal of Medicine 1990; 322: 1430–1434
- McLaughlin P., Hagemeister F., Romaguera J., et al. CHOP-Bleo plus α-interferon for stage IV low grade lymphoma. Blood 1988; 72(Suppl. 1)165a, (abstr.)
- McLaughlin P., Cabanillas F., Hagemesiter F. B., et al. CHOP-Bleo plus α-interferon (IFN) in stage IV low grade lymphoma. Proceedings of American Society for Clinical Oncology 1992; 11: 326, (abstr.)
- Romaguera J. E., McLaughlin P., North L., et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model. Journal of Clinical Oncology 1991; 9: 762–769
- Smalley R. V., Andersen J. W., Hawkins M. J. Alpha interferon improves the effectiveness of induction chemotherapy in patients with prognostically unfavorable, moderatively aggressive non-Hodgkin's lymphoma. Proceedings of the American Society of Clinical Oncology 1991; 10: 272, (abstr.)
- Solal-Celigny Ph., Lepage E., Brousse N., et al. Alpha-interferon and chemotherapy in patients with high-tumor burden follicular lymphoma: preliminary results of the “groupe d'etude des lymphomes folliculaires” (GELF). Proceedings of the American Society of Clinical Oncology 1991; 10: 275, (abstr.)